Cite

    Gault, L. et al. (2016). ABT-126 monotherapy in mild-to-moderate Alzheimer's dementia: randomized double-blind, placebo and active controlled adaptive trial and open-label extension. Alzheimer's research & therapy. 8 (1), pp. 1-13. [Online].